V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280010493 | 280010669 | 1.84 | 75.1 | Curative (C) | 2012-03-31 | 2013-07-31 | Capecitabine (14 days)+Carboplatin | 02 | N | 280028993 | CHLORAMBUCIL |
| 280010494 | 280009174 | 1.66 | null | Neo-adjuvant (N) | 2016-03-20 | 2017-05-01 | Bortezomib + Cyclophos + Dex | N | N | 280029001 | EVEROLIMUS |
| 280010495 | 280009174 | 1.67 | 100.2 | Palliative (P) | 2016-10-14 | 2016-10-14 | Dacarbazine | 2 | N | 280029001 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280010496 | 280006058 | 1.85 | 100.8 | Palliative (P) | 2015-04-24 | 2015-04-24 | LANREOTIDE | N | Y | 280029006 | CISPLATIN + FLUOROURACIL + RT |
| 280010497 | 280010671 | 1.87 | 48.05 | Neo-adjuvant (N) | 2019-02-18 | 2019-04-12 | NIVOLUMAB | N | N | 280029007 | CAPECITABINE + CISPLATIN |
| 280010498 | 280006060 | 1.33 | null | Curative (C) | 2018-02-06 | 2018-02-18 | Carbo F | N | N | 280029009 | CISPLATIN + DOXORUBICIN |
| 280010499 | 280006064 | 1.79 | 76.9 | Not known (9) | 2018-09-01 | 2018-09-01 | VIDE | N | N | 280029014 | NIVOLUMAB |
| 280010500 | 280006066 | null | null | Curative (C) | 2016-09-02 | 2016-09-03 | BCG Intravesical | 02 | null | 280029015 | CISPLATIN + FLUOROURACIL + RT |
| 280010501 | 280006071 | 1.62 | 75 | Palliative (P) | 2016-12-03 | 2016-12-05 | DARS Trial | null | null | 280029021 | PAZOPANIB |
| 280010502 | 280006075 | 1.83 | 52.3 | Palliative (P) | 2014-08-27 | 2014-09-01 | EpSSG NRSTS 2005 | 02 | N | 280029036 | LIPOSOMAL DOXORUBICIN |
| 280010503 | 280010676 | null | 66.2 | Palliative (P) | 2015-11-03 | 2015-11-10 | Vinorelbine (oral) | 02 | N | 280029038 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280010504 | 280010676 | 1.74 | 66.9 | Palliative (P) | 2019-04-22 | 2019-05-20 | PEMBROLIZUMAB | N | N | 280029038 | CISPLATIN + FLUOROURACIL + RT |
| 280010505 | 280006077 | 1.7 | 61 | Disease modification (D) | 2017-03-07 | 2017-03-07 | BUSULFAN + MELPHALAN | 02 | N | 280029044 | IVADO |
| 280010506 | 280006082 | 168 | null | Palliative (P) | 2015-06-17 | 2015-06-26 | Bortezomib +/- Dexamethasone | 2 | Y | 280029057 | DACTINOMYCIN + VINCRISTINE |
| 280010507 | 280006086 | 0 | 80.55 | Curative (C) | 2019-05-31 | 2019-06-06 | VINCRISTINE | null | null | 280029062 | VINCRISTINE |
| 280010508 | 280006088 | 1.73 | null | Palliative (P) | 2014-08-01 | 2014-08-01 | Docetaxel | 02 | N | 280029070 | VINORELBINE |
| 280010509 | 280006091 | 1.64 | 74.8 | Palliative (P) | 2018-02-08 | 2018-02-14 | CISPLATIN + ETOPOSIDE | 2 | N | 280029081 | KESTREL TRIAL |
| 280010510 | 280006092 | 1.71 | null | Palliative (P) | 2016-06-06 | 2016-06-13 | PERTUZUMAB + TRASTUZUMAB | N | null | 280029090 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280010511 | 280006095 | 1.82 | 61.3 | Palliative (P) | 2018-05-18 | 2018-05-25 | Dacarbazine | N | N | 280029095 | CAPECITABINE |
| 280010512 | 280011405 | 1.8 | null | Neo-adjuvant (N) | 2016-11-28 | 2016-11-28 | IVADo | N | N | 280029101 | IRINOTECAN + VINCRISTINE |
| 280010513 | 280011937 | null | 55 | Curative (C) | 2017-01-02 | 2017-01-31 | ABVD | 01 | N | 280029101 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE |
| 280010514 | 280006099 | 1.59 | 65 | Palliative (P) | 2016-08-08 | 2016-08-11 | Cisplatin + Fluorouracil + RT 5day | N | N | 280029113 | LIPOSOMAL DOXORUBICIN |
| 280010515 | 280006100 | 0 | 50.8 | Palliative (P) | 2015-07-09 | 2016-07-27 | CAPECITABINE + CARBOPLATIN | 02 | N | 280029116 | DOCETAXEL |
| 280010516 | 280006102 | 1.8 | 78 | Palliative (P) | 2016-05-10 | 2016-12-19 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | 280029119 | SUNITINIB |
| 280010517 | 280006104 | 1.81 | 77 | Adjuvant (A) | 2015-10-28 | 2015-11-05 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 02 | N | 280029120 | VINORELBINE |
| 280010518 | 280009200 | 1.6 | null | null | 2014-10-29 | 2015-06-02 | Capecitabine + Cisplatin | N | N | 280029129 | CAPECITABINE + MITOMYCIN |
| 280010519 | 280009201 | null | 61.7 | Curative (C) | 2018-06-09 | 2018-06-29 | OCTREOTIDE | N | N | 280029135 | OCTREOTIDE |
| 280010520 | 280006107 | 1.79 | 55 | Curative (C) | 2014-11-16 | 2014-12-07 | FEC | null | Y | 280029140 | VIA |
| 280010521 | 280006109 | 1.78 | null | Adjuvant (A) | 2015-05-25 | 2015-05-26 | TIMELY TRIAL | N | null | 280029142 | CISPLATIN + DOXORUBICIN |
| 280010522 | 280006111 | null | 72 | Palliative (P) | 2014-10-06 | 2014-11-26 | STS Rhabdo VIT0910 Vinc Irinotecan | N | N | 280029149 | VIDE |
| 280010523 | 280006112 | null | 51.4 | Curative (C) | null | 2013-12-27 | Docetaxel 100mg/m2 (21 day) | N | N | 280029152 | TRASTUZUMAB |
| 280010524 | 280006115 | null | 75.1 | Curative (C) | 2013-05-07 | 2013-05-07 | CAPECITABINE + CETUXIMAB + CISPLATIN | null | null | 280029156 | LIPOSOMAL DOXORUBICIN |
| 280010525 | 280009206 | 0 | 60 | Adjuvant (A) | 2017-04-29 | 2017-05-05 | Carboplatin + Vinorelbine IV | 2 | N | 280029169 | IFOSFAMIDE + VINCRISTINE |
| 280010526 | 280009207 | 1.81 | 65.5 | Curative (C) | 2014-04-11 | 2014-05-09 | Carbo F | 2 | N | 280029172 | DACTINOMYCIN + VINCRISTINE |
| 280010527 | 280006122 | 0 | 11.1 | Curative (C) | 2013-07-11 | 2014-05-11 | Carbo F | N | N | 280029179 | DACARBAZINE |
| 280010528 | 280009208 | 0 | 52 | Curative (C) | 2014-04-20 | 2014-11-29 | LIPOSOMAL DOXORUBICIN | null | null | 280029180 | PEMBROLIZUMAB |
| 280010529 | 280006125 | 0 | 61.8 | Palliative (P) | 2013-04-24 | 2013-04-25 | IVADo | 02 | N | 280029192 | FLUOROURACIL + MITOMYCIN + RT |
| 280010530 | 280006128 | 1.77 | 42.3 | Curative (C) | 2017-10-04 | 2018-05-01 | Cyclophosphamide + Vincristine | N | N | 280029210 | DACTINOMYCIN + VINCRISTINE |
| 280010531 | 280006131 | null | 84.7 | Palliative (P) | 2013-07-20 | 2013-07-29 | Folfirinox | 02 | N | 280029221 | VIDE |
| 280010532 | 280006131 | 1.78 | null | Curative (C) | 2013-04-17 | 2013-10-13 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | N | N | 280029221 | VINCRISTINE |
| 280010533 | 280006133 | 1.7 | 71 | Curative (C) | 2016-05-24 | 2016-06-18 | Methotrexate intrathecal | N | N | 280029255 | MITOMYCIN INTRAVESICULAR |
| 280010534 | 280006136 | 1.87 | 77.05 | Curative (C) | 2016-05-21 | 2016-05-30 | PACLITAXEL + TRASTUZUMAB | N | N | 280029257 | IDELALISIB |
| 280010535 | 280006139 | 1.76 | 108 | null | 2014-03-31 | 2017-05-31 | Capecitabine (21days) + Carboplatin | N | null | 280029282 | CARBOPLATIN + CETUXIMAB + FU |
| 280010536 | 280006140 | 1.57 | 83 | Curative (C) | 2014-07-10 | 2018-03-13 | CHOP R - 21 days | 02 | N | 280029291 | CISPLATIN + FLUOROURACIL + RT |
| 280010537 | 280006142 | 1.82 | 56.2 | Palliative (P) | 2014-07-19 | 2015-12-19 | Capecitabine + Oxaliplatin 21day | Y | N | 280029293 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280010538 | 280006143 | 1.6 | 81 | Neo-adjuvant (N) | 2015-06-22 | 2015-06-22 | Carboplatin + Liposomal Doxorubicin | N | N | 280029301 | KESTREL TRIAL |
| 280010539 | 280006146 | 1.65 | 70 | Palliative (P) | 2018-01-26 | 2018-03-02 | Pazopanib | N | N | 280029308 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 280010540 | 280009219 | 1.62 | 83 | Curative (C) | 2014-03-17 | 2014-10-04 | ECX | N | N | 280029309 | VIDE |
| 280010541 | 280010698 | 1.71 | null | Palliative (P) | 2015-11-03 | 2017-12-28 | CYCLOPHOSPHAMIDE + VINORELBINE | null | N | 280029312 | MELPHALAN |
| 280010542 | 280010698 | 1.56 | null | Curative (C) | 2017-10-16 | 2017-12-12 | CAPECITABINE + TEMOZOLOMIDE | 2 | N | 280029312 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE |